🔥 BREAKING 🔥 U.S. FDA approved REZZAYO™ (rezafungin inj) novel once-weekly echinocandin for the treatment of candidemia & invasive candidiasis in adults with limited or no alternative treatment options #IDTwitter FungalDoc: moved to bluesky Bug Pharmacist 💊🧫 Tim Gauthier Infectious Diseases globenewswire.com/news-release/2…

A little late, but had a great time this past week at my first #IDWeek! Got to spend time with some amazing people in Boston. Incredibly thankful to be able to present my poster at the conference too. Already looking forward to next year! IDWeek SIDP PENN ID

CCF ID Tuesday Transplant Lecture This week, was by Dr. Thomas Rust, PharmD,on “Pearls in Transplant Pharmacology.” 💊 A great insight on an important topic #IDfellows #TxID

Antimicrobial Stewardship in Patients With Cancer: Interventions and Future Directions to Combat the Rise of Antimicrobial Resistance | JCO Oncology Practice Thank you Aneela Majeed for the excellent editorial ascopubs.org/doi/10.1200/OP…

Fantastic work by our Transplant ID pharmacist, Dr. Rust on pre- and post-intervention analysis of CMV resistance testing stewardship. A great example of antimicrobial stewardship in action—improving test utility while saving costs! 💊 #WTC2025 #TransplantID